The software, developed by researchers at the Ontario Institute for Cancer Research, uses machine learning methods to classify mutations as germline or somatic.
The initiatives are being funded with C$24 million over two years and will focus on acute leukemia, immuno-oncology, and brain, ovarian, and pancreatic cancer.
Two research groups reported on statistical methods for uncovering methylated cytosine and/or adenine bases using electrical current cues from Oxford Nanopore sequencers.
In two studies, researchers sequenced nearly 500 tumors to uncover hallmarks of aggressive prostate cancer.
An analysis of copy number changes and genomic rearrangements in more than 100 tumors suggests chromothripsis may contribute to pancreatic cancer evolution.
The Ontario Institute for Cancer Research will work with prostate cancer data while Dana Farber Cancer Institute's pilot has yet to be decided.
The partners will work on pilot projects that use novel analytical approaches to explore oncology molecular and imaging data.
Researchers in Canada and the UK have used data from the Oxford Nanopore MinIon alone to assemble a bacterial genome into a single contig.
The International Cancer Genome Consortium has selected Annai Systems to host data from more than 10,000 human cancer genomes.
NEW YORK (GenomeWeb) – In Nature Genetics, researchers from the Memorial Sloan Kettering Cancer Center, the Ontario Institute for Cancer Research, the University of Toronto, and elsewhere described
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.